ERBB2 c.2705A>G ;(p.Q902R)

Variant ID: 17-37881635-A-G

NM_004448.2(ERBB2):c.2705A>G;(p.Q902R)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines.

Molecular Oncology
Keller, Simone S; Zwingenberger, Gwen G; Ebert, Karolin K; Hasenauer, Jan J; Wasmuth, Jacqueline J; Maier, Dieter D; Haffner, Ivonne I; Schierle, Katrin K; Weirich, Gregor G; Luber, Birgit B
Publication Date: 2018-04

Variant appearance in text: ERBB2: Q902R
PubMed Link: 29325228
Variant Present in the following documents:
  • MOL2-12-441-s001.pdf
View BVdb publication page



Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer.

Oncotarget
Arienti, Chiara C; Zanoni, Michele M; Pignatta, Sara S; Del Rio, Alberto A; Carloni, Silvia S; Tebaldi, Michela M; Tedaldi, Gianluca G; Tesei, Anna A
Publication Date: 2016-04-05

Variant appearance in text: HER2: Q902R
PubMed Link: 26919099
Variant Present in the following documents:
  • Main text
  • oncotarget-07-18424.pdf
View BVdb publication page